Myriad RBM HumanMAPs

A Multi-Analyte-Profile (MAP) combining analytes most commonly associated with cardiovascular disease. Like all Myriad RBM MAPs, it is used to identify useful patterns indicative of the effects of either disease or therapeutic intervention. Myriad RBM’s MAP approach provides investigators with a reliable platform and quantitative immunoassay data that can help discern biomarker patterns in a cost-effective, efficient process.

Click or mouse over biomarkers for more information. Analytes included in this MAP are subject to change.
1. Adiponectin2. Antithrombin-III
3. Apolipoprotein A-I4. Apolipoprotein A-II
5. Apolipoprotein B6. Apolipoprotein C-I
7. Apolipoprotein C-III8. Apolipoprotein D
9. Apolipoprotein E10. Apolipoprotein H
11. Apolipoprotein(a)12. C-Reactive Protein
13. CD 40 antigen14. CD40 Ligand
15. Chromogranin-A16. Clusterin
17. Cystatin-C18. E-Selectin1
19. EN-RAGE20. Factor VII
21. Fatty Acid-Binding Protein, heart22. Ferritin
23. Fetuin-A24. Fibrinogen
25. Ficolin-326. Granulocyte Colony-Stimulating Factor
27. Granulocyte-Macrophage Colony-Stimulating Factor28. Haptoglobin
29. Immunoglobulin M30. Insulin
31. Intercellular Adhesion Molecule 132. Interferon gamma
33. Interferon gamma Induced Protein 1034. Interleukin-1 alpha
35. Interleukin-1 beta36. Interleukin-10
37. Interleukin-1838. Interleukin-6
39. Interleukin-6 receptor40. Interleukin-8
41. Lectin-Like Oxidized LDL Receptor 142. Leptin
43. Leucine-rich alpha-2-glycoprotein44. Macrophage Inflammatory Protein-1 alpha
45. Macrophage Inflammatory Protein-1 beta46. Matrix Metalloproteinase-1
47. Matrix Metalloproteinase-1048. Matrix Metalloproteinase-3
49. Matrix Metalloproteinase-750. Matrix Metalloproteinase-9
51. Matrix Metalloproteinase-9, total52. Monocyte Chemotactic Protein 1
53. Myeloperoxidase54. Myoglobin
55. N-terminal prohormone of brain natriuretic peptide56. Neuropilin-1
57. Neutrophil Activating Peptide 258. P-Selectin1
59. Pigment Epithelium Derived Factor60. Plasminogen Activator Inhibitor 1
61. Pulmonary and Activation-Regulated Chemokine62. Receptor for advanced glycosylation end products
63. Serotransferrin64. Serum Amyloid A Protein2
65. Serum Amyloid P-Component66. Sex Hormone-Binding Globulin
67. T-Cell-Specific Protein RANTES68. Thrombin-Activatable Fibrinolysis
69. Thrombomodulin70. Thyroxine-Binding Globulin
71. Tissue Inhibitor of Metalloproteinases 172. Tumor Necrosis Factor alpha
73. Tumor necrosis factor receptor 274. Vascular Cell Adhesion Molecule-1
75. Vascular Endothelial Growth Factor76. Vitamin K-Dependent Protein S
77. von Willebrand Factor

1 This assay did not meet performance specifications in EDTA-Plasma and results should be used for information purposes only.

2 This assay did not meet performance specifications in Serum and results should be used for information purposes only.

Intended for Research Use Only.

Serum or plasma Other fluids*
200 µL 700 µL
*Cerebrospinal fluid, urine, tissue culture supernatants,  bronchoalveolar lavage, synovial fluid, tissue extracts, tears, skin washings, etc.

Bibliography

Cancer

There are no Bibliographies for this Therapy Indication

Every Order Starts With a Quote

Thank you for your interest in Myriad RBM's innovative biomarker solutions. Please tell us more about what you would like to order and provide us with your details, so we can get back to you with a quote.